Journal: European Journal of Medical Research
Article Title: The role of CSTF2 in gastric cancer: implications for therapy
doi: 10.1186/s40001-025-03570-8
Figure Lengend Snippet: Screening of the downstream gene TGM2. A Venn diagram showing the number of downregulated genes after knockdown of CSTF2 in BGC-823 and MKN-28 cells, with 15 genes overlapping. B mRNA expression levels of CSTF2 and TGM2 after CSTF2 knockdown in different groups, as determined by qRT-PCR. C Spearman correlation analysis of the expression levels between CSTF2 and TGM2. D Protein expression levels of CSTF2 and TGM2 after CSTF2 knockdown, as assessed by western blotting. E BGC-823 and MKN-28 cells were treated with actinomycin D (10 ug/ml) and harvested at 0, 2, 4, 6, and 8 h for RNA extraction. TGM2 mRNA levels were measured by qPCR at the different timepoints, using GAPDH as input control. F Representative immunohistochemistry (IHC) images of TGM2 expression in gastric cancer tissues and adjacent normal tissues (magnification: 200x). All experiments were independently repeated at least three times. Statistical significance was determined by a two-tailed independent t test (* P < 0.05, ** P < 0.01, *** P < 0.001)
Article Snippet: Antibodies against CSTF2 (1:1000; sc-374373; Santa Cruz Biotechnology, USA) and TGM2 (1:1000; sc-21733; Santa Cruz Biotechnology, USA) were used.
Techniques: Knockdown, Expressing, Quantitative RT-PCR, Western Blot, RNA Extraction, Control, Immunohistochemistry, Two Tailed Test